Publications 2019- Equipe Inserm 1

  • Morello E, Pérez-Berezo T, Boisseau C, Baranek T, Guillon A, Bréa D, Lanotte P, Carpena X, Pietrancosta N, Hervé V, Ramphal R, Cenac N, Si-Tahar M. Pseudomonas aeruginosa Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid Signaling. Front Microbiol. 2019 Aug 14;10:1826
  • Guillon A, Darrouzain F, Heuze-Vourc'H N, Petitcollin A, Barc C, Vecellio L, Cormier B, Lanotte P, Sarradin P, Dequin PF, Paintaud G, Ehrmann S. Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets. Pulm Pharmacol Ther. 2019 May 15:101807. doi: 10.1016/j.pupt.2019.101807. [Epub ahead of print]  
  • Georgel AF, Cayet D, Pizzorno A, Rosa-Calatrava M, Paget C, Sencio V, Dubuisson J, Trottein F, Sirard JC, Carnoy C. Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir. Antiviral Res. 2019 May 9;168:28-35. doi: 10.1016/j.antiviral.2019.05.002. [Epub ahead of print]
  • Mogilenko DA, Haas JT, L'homme L, Fleury S, Quemener S, Levavasseur M, Becquart C, Wartelle J, Bogomolova A, Pineau L, Molendi-Coste O, Lancel S, Dehondt H, Gheeraert C, Melchior A, Dewas C, Nikitin A, Pic S, Rabhi N, Annicotte JS, Oyadomari S, Velasco-Hernandez T, Cammenga J, Foretz M, Viollet B, Vukovic M, Villacreces A, Kranc K, Carmeliet P, Marot G, Boulter A, Tavernier S, Berod L, Longhi MP, Paget C, Janssens S, Staumont-Sallé D, Aksoy E, Staels B, Dombrowicz D. Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR. Cell. 2019 May 16;177(5):1201-1216.e19. doi: 10.1016/j.cell.2019.03.018. Epub 2019 Apr 25.
  • Jouan Y, Si-Tahar M, Paget C. Severe pneumonia and acute respiratory distress syndrome: Implication of unconventional T cells. Rev Mal Respir. 2019 Apr;36(4):451-454. doi: 10.1016/j.rmr.2019.03.007. Epub 2019 Apr 17. French.
  • Sécher T, Dalonneau E, Ferreira M, Parent C, Azzopardi N, Paintaud G, Si-Tahar M, Heuzé-Vourc'h N. In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration. J Control Release. 2019 Apr 11;303:24-33. doi: 10.1016/j.jconrel.2019.04.005. [Epub ahead of print]
  • Magnen M, Gueugnon F, Petit-Courty A, Baranek T, Sizaret D, Brewah YA, Humbles A, Si-Tahar M, Courty Y. Tissue kallikrein (KLK1) regulates alveolar macrophage apoptosis early in influenza virus infection. Am J Physiol Lung Cell Mol Physiol. 2019 Mar 25. doi: 10.1152/ajplung.00379.2018. [Epub ahead of print]
  • Paget C, Deng S, Soulard D, Priestman DA, Speca S, von Gerichten J, Speak AO, Saroha A, Pewzner-Jung Y, Futerman AH, Mallevaey T, Faveeuw C, Gu X, Platt FM, Sandhoff R, Trottein F. TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells. PLoS Biol. 2019 Mar 1;17(3):e3000169. doi: 10.1371/journal.pbio.3000169.
  • Paget C, Trottein F. Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells. Front Immunol. 2019 Mar 1;10:336. doi: 10.3389/fimmu.2019.00336. eCollection 2019. Review.
  • Guillon A, Pardessus J, Lhommet P, Parent C, Respaud R, Marchand D, Montharu J, De Monte M, Janiak P, Boixel C, Audat H, Huille S, Guillot E, Heuze-Vourc'h N. Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis. MAbs. 2019 Feb/Mar;11(2):297-304. doi: 10.1080/19420862.2018.1556081. Epub 2019 Feb 4.
  • Guillon A, Brea D, Luczka E, Hervé V, Hasanat S, Thorey C, Pérez-Cruz M, Hordeaux J, Mankikian J, Gosset P, Coraux C, Si-Tahar M. Inactivation of the interleukin-22 pathway in the airways of cystic fibrosis patients. Cytokine. 2019 Jan. doi: 10.1016/j.cyto.2018.10.015. Epub 2018 Oct 28